companydata.dkAVILEX PHARMA ApS: Financial statements 2014
CVR: 34896828
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2014. In 2014, the company reported a net result of DKK -1,224,080 compared with DKK -2,948,947 the year before. Equity amounted to DKK -4,093,027.
- Profit/Loss
- -1,224,080 kr.
- Equity
- -4,093,027 kr.
- Total Assets
- 1,271,519 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | - | -1.2 mio. | -4.1 mio. | 0 |
| 2013 | - | - | -2.9 mio. | -2.9 mio. | - |
Keep an eye on AVILEX PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of AVILEX PHARMA ApS.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of AVILEX PHARMA ApS.
As of September 2, 2014, Bobby G Soni has joined the board of directors of AVILEX PHARMA ApS.
As of September 2, 2014, Henrijette Elsebeth Richter has left the board of directors of AVILEX PHARMA ApS.
AVILEX PHARMA ApS has published its annual report for 2013. The net result was DKK -2,948,947.
As of January 2, 2014, Henrijette Elsebeth Richter has joined the board of directors of AVILEX PHARMA ApS.
As of January 2, 2014, Ingelise Saunders has left the board of directors of AVILEX PHARMA ApS.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees. In 2024, the company reported a net result of DKK -4,428,000 compared with DKK -6,756,000 the year before. Equity amounted to DKK -6,267,000.